Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review
Open Access
- 1 August 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Infection and Drug Resistance
- Vol. ume 13, 2657-2665
- https://doi.org/10.2147/idr.s264020
Abstract
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the related disease (COVID-19) has spread rapidly to pandemic proportions, increasing the demands on healthcare systems for the containment and management of COVID-19. One of the critical issues to be addressed is the improvement in laboratory diagnosis and screening of large portions of the population to stop the virus spreading. Currently, the laboratory diagnosis of SARS-CoV-2 infection and the related disease is based on the research of viral RNA with rt-PCR methods in upper and lower respiratory airways. Serological tests to detect SARS-CoV-2 antibodies could help physicians and healthcare workers to support COVID-19 diagnosis and follow-up and perform population screening. Our review, using MEDLINE and EMBASE, summarizes the current knowledge of direct and serological tests performed to research RNA, antigens, or antibodies for SARS-CoV-2, evaluating the advantages and drawbacks for specific tests.Keywords
This publication has 68 references indexed in Scilit:
- Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionJCI Insight, 2019
- Origin and evolution of pathogenic coronavirusesNature Reviews Microbiology, 2018
- Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domainsNature Communications, 2017
- Structure, Function, and Evolution of Coronavirus Spike ProteinsAnnual Review of Virology, 2016
- SARS and MERS: recent insights into emerging coronavirusesNature Reviews Microbiology, 2016
- Pre-fusion structure of a human coronavirus spike proteinNature, 2016
- Antibody responses against SARS coronavirus are correlated with disease outcome of infected individualsJournal of Medical Virology, 2005
- Antigenic Cross‐Reactivity between Severe Acute Respiratory Syndrome–Associated Coronavirus and Human Coronaviruses 229E and OC43The Journal of Infectious Diseases, 2005
- Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome VirusThe New England Journal of Medicine, 2004